Ascendis Pharma A/S Net Income

Ascendis Pharma A/S (ASND) currently reports a net income of $760M as of June 2026. That compares with $-270M in the prior-year period — up 378.8% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Ascendis Pharma A/S's net income history and peer comparisons.

Ascendis Pharma A/S's net income increased from $-270M to $760M — a 378.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ascendis Pharma A/S's net income of $760M is lower than the Healthcare sector average of $16B. That is roughly 95.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Ascendis Pharma A/S reported $760M in net income as of June 2026. That compares with $-270M in the prior-year period — up 378.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $760M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Ascendis Pharma A/S, and consider following ASND for alerts when major investors trade the stock.